Revolutionizing Disease Treatment: Cellino's Breakthrough Technology Makes Personalized Stem Cell Therapies Affordable

For decades, researchers have sought to harness the potential of stem cells to treat debilitating diseases such as Parkinson's and Type 1 diabetes. However, the high cost of creating induced pluripotent stem cells (iPSCs) has hindered progress. Biotech startup Cellino is poised to change this landscape with its innovative technology, Nebula, which promises to reduce manufacturing costs by at least 10 times.